Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02139930 · ClinicalTrials.gov registry record · NA
Project 2: Strategies for Reducing Nicotine Content in Cigarettes
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 1,250
- Enrollment target
NCT02139930: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT02139930 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 1,250 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (11% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02139930, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,250 participants
- Enrollment target
Study Summary
The main goal of this project is to compare two different approaches to reducing levels of nicotine in cigarettes: an immediate reduction in nicotine content in cigarettes to non-addictive levels or a gradual reduction in nicotine content in cigarettes to non-addictive levels. These two approaches will then be contrasted to a group that continues to smoke cigarettes with nicotine content similar to conventional cigarettes.
Primary Outcome
Between group comparison of expired air carbon monoxide (CO) values at week 20 using baseline CO values as a covariate.
Interventions
- BEHAVIORAL Normal Nicotine Control Group
- BEHAVIORAL Immediate Nicotine Reduction Group
- BEHAVIORAL Gradual Nicotine Reduction Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,250 participants |
| Start Date | 2014-09 |
| Est. Completion | 2017-03-14 |
| Phase | NA |
What the finished NCT02139930 record still lists
NCT02139930 is an interventional study that assigns participants to a tested intervention. Its 1,250 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (11% lower).
The record links to 0 conditions, and to 3 interventions - of which Normal Nicotine Control Group is the first listed.
NCT02139930 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02139930 about?
NCT02139930 is a clinical study titled "Project 2: Strategies for Reducing Nicotine Content in Cigarettes". The main goal of this project is to compare two different approaches to reducing levels of nicotine in cigarettes: an immediate reduction in nicotine content in cigarettes to non-addictive levels or a gradual reduction in nicotine content in cigarettes to non-addictive levels. These two approaches w...
What is the current status of trial NCT02139930?
This trial is currently completed. It is a NA study. The enrollment target is 1,250 participants. The study started on 2014-09. Estimated completion is 2017-03-14.
What interventions are being tested in trial NCT02139930?
The interventions under investigation include: Normal Nicotine Control Group (BEHAVIORAL), Immediate Nicotine Reduction Group (BEHAVIORAL), Gradual Nicotine Reduction Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT02139930?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02139930's enrollment target sits among peer trials
1,250 80th of 2000 higher than 1,919 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02743858 · 1,250 participants
Lymphedema Surveillance Study
- NCT04670874 · 1,250 participants
Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
- NCT04807868 · 1,250 participants
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
- NCT05995821 · 1,250 participants
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia